Endo International Ordinary Shares reported $181.61M in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbvie ABBV:US $ 6290M 282M
Amarin AMRN:US $ 8.87M 9.87M
Ani Pharmaceuticals ANIP:US $ 11.04M 5.43M
Antares Pharma ATRS:US $ 5.56M 1.18M
Biodelivery Sciences International BDSI:US $ 9.38M 3.92M
Eli Lilly And LLY:US $ 1988.6M 80.6M
Endo International Ordinary Shares ENDP:US $ 181.61M 22.56M
Flexion Therapeutics FLXN:US $ -22208000 6.35M
Heron Therapeutics HRTX:US $ -61.02M 8.4M
Ligand Pharmaceuticals LGND:US $ 34.99M 4.55M
Novartis NOVN:VX SF 4424M 620M
Supernus Pharmaceuticals SUPN:US $ 31.24M 20.31M
Teva Pharmaceutical TEVA:IT 794M 650M